Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

Sector: Pharmaceutical Preparations Region: MD, United States

: | Nasdaq: NWBO | Nasdaq: NWBOW

Similar to: Cephalon, Inc., Nicox SA, Hutchison China MediTech Ltd.

Northwest Biotherapeutics, Inc. is a development stage company which is engaged in the development and discovery of innovative immunotherapy products to treat cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

News & Analysis

You may also be interested in: